Standout Papers

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods 2020 2026 2022 20241.6k
  1. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods (2020)
    Canrong Wu, Yang Liu et al. Acta Pharmaceutica Sinica B

Citation Impact

Citing Papers

COVID-19 Infection
2020
Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
2020 Science
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
2020 StandoutScience
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
Long COVID: major findings, mechanisms and recommendations
2023 Standout
Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach
2020
Coronavirus biology and replication: implications for SARS-CoV-2
2020 Standout
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases
2019 StandoutNobel
Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development
2020
A comprehensive investigation of the mRNA and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells
2020
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
2020 Standout
Discovery of a potent non-oxime reactivator of nerve agent inhibited human acetylcholinesterase
2018
Literature-based review of the drugs used for the treatment of COVID-19
2020
COVID-19: A promising cure for the global panic
2020 Standout
Inhibition of transforming growth factor-β via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis
2015
Current advances in the synthesis and biological potencies of tri- and tetra-substituted 1H-imidazoles
2015
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
2020
Case Report: Famotidine for Neuropsychiatric Symptoms in COVID-19
2020
Counteracting tabun inhibition by reactivation by pyridinium aldoximes that interact with active center gorge mutants of acetylcholinesterase
2019 StandoutNobel
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review
2020
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
2020 StandoutNature
COVID-19: consider cytokine storm syndromes and immunosuppression
2020 Standout
Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19
2020
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Novel guanosine derivatives against MERS CoV polymerase: An in silico perspective
2020
Cholinesterase reactivators and bioscavengers for pre‐ and post‐exposure treatments of organophosphorus poisoning
2017
Comprehensive Review in Current Developments of Imidazole-Based Medicinal Chemistry
2013
Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals
2020 Standout
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
2020 Standout
Molecular Docking Analysis of Selected Natural Products from Plants for Inhibition of SARS-CoV-2 Main Protease
2020
An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
2020 Standout
Antioxidant, Antimicrobial and Antiviral Properties of Herbal Materials
2020 Standout
Machine learning-based approach: global trends, research directions, and regulatory standpoints
2021 Standout
Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services
2020 Standout
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
2020 Standout
Reversal of Tabun Toxicity Enabled by a Triazole‐Annulated Oxime Library—Reactivators of Acetylcholinesterase
2018 StandoutNobel
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic
2020
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout

Works of Xingzhou Li being referenced

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
2020 Standout
Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles and 1,3,5-trisubstituted pyrazoles as inhibitors of transforming growth factor β type 1 receptor (ALK5)
2009
Novel nonquaternary reactivators showing reactivation efficiency for soman-inhibited human acetylcholinesterase
2016
Antagonism of Transforming Growth Factor-Β Signaling Inhibits Fibrosis-Related Genes
2005
Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles as inhibitors of transforming growth factor-β type I receptor (ALK5)
2013
Short Synthesis of 1-(3-tert-Butyl-1-phenyl-1H-pyrazol-5-yl)-3-(5-(2-morpholinoethoxy)-2H-chromen-8-yl) Urea Derivatives
2009
Rankless by CCL
2026